Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for chronic central serous chorioretinopathy show promise in preventing permanent vision loss.

Blocking the mineralocorticoid receptor can help treat skin thinning caused by steroids.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Blocking the mineralocorticoid receptor improves wound healing by reducing inflammation and promoting blood vessel growth.

Polycystic Ovary Syndrome (PCOS) often leads to severe acne, and lifestyle changes and hormonal treatments can help manage it.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Some dermatological medications can impair male fertility, so consult a doctor before trying to conceive.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Anti-androgens are effective for female acne but less so for male-pattern hair loss, with side effects similar to birth control pills.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Adrenal disorders often cause high blood pressure in young people.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.